Mutua Madrileña and Banco Sabadell's InnoCells unit provided half of a $23.2m round for Antai Venture Builder.

The second tranche of an Astremedia and Channel 4-backed series B round increased it to $36m, as hiring platform Job Today looks to UK growth.

Novartis and Astellas Venture Management both invested as the gene therapy developer announced its first external funding.

ProSiebenSat.1 has taken a 25% stake in a fund being raised by growth equity firm 7 Global Capital, which is halfway to its $150m target.

FoodShot Global, set up by partners including Rabobank, is looking to supply $10m in equity funding and $20m of debt to innovative food startups.

TAL Education's Win-Win Fund co-led a $17.5m round for All Dream Network Technology, operator of a coding education platform.

Ping An Global Voyager Fund, Clal Insurance, Phoenix Insurance, Caesarea Medical and Foxconn all backed the diagnostics technology developer.

The fibre optic network operator raised the cash in a round co-led by Mitsui, and is looking to add a $40m debt facility.

The healthcare communication platform developer has closed a $40.5m round backed by several health insurers and care providers.

Silverback Therapeutics, which is developing drugs that will only act at the site of disease, has closed a $47.5m round backed by Celgene.